Trials Starting With "D"

Dabigatran among OAC

      -Update in ESC by Dr. Ken Okumura (ESC 2012)

      -Update in ESC by Dr. Ken Okumura (ESC 2012) Japanese

 

Dal-OUTCOMES: Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome

      -Trial Overview by Dr. Gregory G. Schwartz (AHA 2012)

 

DANAMI-2: DANish trial in Acute Myocardial Infarction-2

      -A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction by Dr. Henning Rud Andersen

      -Danish Trial in Acute Myocardial Infarction-2 by Dr. Henning Rud Andersen (ACC 2002)

 

DANPACE: Danish Multicenter Randomized Trial on AAIR Versus DDDR Pacing in Sick Sinus Syndrome

   -Trial Overview by Dr. Jens C. Nielsen (ESC 2010)

 

DEB-AMI: Drug Eluting Balloon in Myocardial Infarction

      -6 Month Trial Results by Dr. Pieter R. Stella (TCT 2011)

DECREASE: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo

      -DECREASE Study Design and Results by Dr. Seong Wook Park (TCT 2008)

DEDICATION: Drug Elution And Distal Protection In St-Elevation Myocardial Infarction

      -DEDICATION by Dr. Leif Thuesen Spanish

      -DEDICATION Trial by Dr. Leif Thuesen (ACC 2007)

DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

      -Study Overview by Dr. James Min (ESC 2012)

DEFER: Deferral Versus Performance Of PTCA In Patients Without Documented Ischemia

      -Long-Term Clinical Outcome of Mild Coronary Stenosis by Dr. Nico H. J. Pijls (ESC 2007)

      -DEFER Study 5-Year Follow-Up by Dr. Nico H. J. Pijls

 

DEFINE: Determining the Efficacy of Tolerability of CETP Inhibition With Anacetrapib

      -Trial Results by Dr. Christopher Cannon (AHA 2010)

DELAYED-RRISC: Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent

      -Long-Term Events in Sirolimus-Eluting Stents: A Specific Focus on Diseased Saphenous Vein Grafts from the Randomized DELAYED-RRISC trial by Dr. Pierfrancesco Agostoni

DELIVER: A Multi-Center, Randomized Study of the Paclitaxel-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions

      -A Multi-Center, Randomized Study of the Paclitaxel-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions (ACC 2003)

DEScover Registry: An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting

      -DEScover: One-Year Clinical Results by Dr. David O. Williams and Dr. J. Dawn Abbott (TCT 2006)

 

DESERT: A Large-Scale, Multicenter, Case-Controlled Study Examining the Predictors of Stent Thrombosis

      -Study Overview by Dr. Ron Waksman (TCT 2011)

DETECT: Feasibility Study of an Implantable Device to Monitor ST-Segment Shifts and Alert Patients to Cardiac Ischemia

      -Feasibility Study of an Implantable Device to Monitor ST-Segment Shifts and Alert Patients to Cardiac Ischemia by Dr. David Holmes Jr.

 

DES-BTK: Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease

     -A Prospective, Double-Blind, Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease by Dr. Thomas Zeller (TCT 2010)

 

DFM AV: The Direct Flow Medical Aortic Valve (DFM AV) Prosthesis European Clinical Trial

      -First-in-Human Report: Initial Experience with a Stentless and Retrievable Percutaneous Aortic Valve Prosthesis by Dr. Joachim Schofer (TCT 2008)

DIABETES I: DIABETes and sirolimus Eluting Stent

      -Long-term follow-up of the DIABETES I trial by Dr. P. Jimenez-Quevedo

      -Diabetes and sirolimus eluting stent 9 Month Results (TCT 2004)

DINAMIT: Defibrillator in Acute Myocardial Infarction Trial

      -Trial Overview by Dr. Stewart Connelly and Dr. Stefan H. Hohnloser (ACC 2004)

DIRECT: Direct Stenting Using the Sirolimus-Eluting Stent

      -Direct Stenting Using the Sirolimus-Eluting Stent by Dr. Jeffrey W. Moses (ACC 2004)

DISPERSE 2-TIMI 33:

      -Trial results

DREAM: Diabetes REduction Assessment with ramipril and rosiglitazone Medication

      -DREAM Trial TZS without ACE inhibitors by Dr. Jeffrey L. Probstfield

      -Diabetes REduction Assessment with ramipril and rosiglitazone Medication

Duke Databank

      -Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank

Dutch Stent Thrombosis Registry

      -Long-term Clinical Outcome after First Definite Stent Thrombosis by Dr. J. W. van Werkum

Drug-Eluting Stent Mortality Meta-Analysis

      -Drug-Eluting Stent Mortality Meta-Analysis by Dr. Alain J. Nordmann (ESC 2006)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster